Dyne Therapeutics, Inc. (DYN) Ownership

$24.50

north_east $0.53 (2.21%)
Day's range
$23.48
Day's range
$24.57

Dyne Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 11/13/2024 9.03 M $324.24 M   69.71% 8.95%
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC 11/13/2024 8.02 M $288.08 M   0.00% 7.95%
BLACKROCK FUNDING, INC. /DE 11/13/2024 7.79 M $279.96 M   100.00% 7.73%
VANGUARD GROUP INC 11/13/2024 6.86 M $246.56 M   45.49% 6.80%
RTW INVESTMENTS, LP 11/14/2024 6.82 M $244.93 M   6.76% 6.76%
JANUS HENDERSON GROUP PLC 11/14/2024 6.81 M $244.76 M   47.35% 6.75%
RA CAPITAL MANAGEMENT, L.P. 11/14/2024 6.38 M $229.21 M   5.49% 6.33%
FCPM III SERVICES B.V. 11/14/2024 5.95 M $213.87 M   -24.11% 5.90%
STATE STREET CORP 11/14/2024 3.64 M $130.82 M   13.77% 3.61%
DEEP TRACK CAPITAL, LP 11/14/2024 3.28 M $117.89 M   -17.95% 3.25%
CITADEL ADVISORS LLC 11/14/2024 2.94 M $105.58 M   -31.90% 2.91%
TCG CROSSOVER MANAGEMENT, LLC 11/14/2024 2.65 M $95.19 M   0.00% 2.63%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2024 2.64 M $94.70 M   11.42% 2.61%
ADAGE CAPITAL PARTNERS GP, L.L.C. 11/14/2024 2.40 M $86.31 M   -27.80% 2.38%
VR ADVISER, LLC 11/14/2024 2.17 M $78.09 M   0.00% 2.15%
HOLOCENE ADVISORS, LP 11/14/2024 1.98 M $71.22 M   -4.51% 1.97%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2024 1.86 M $66.80 M   4.78% 1.84%
JENNISON ASSOCIATES LLC 11/08/2024 1.35 M $48.38 M   1.49% 1.34%
FRANKLIN RESOURCES INC 11/27/2024 1.34 M $44.72 M   -21.70% 1.33%
FIRST LIGHT ASSET MANAGEMENT, LLC 11/14/2024 1.26 M $45.16 M   228.76% 1.25%
ARMISTICE CAPITAL, LLC 11/14/2024 1.16 M $41.49 M   18.98% 1.15%
SIREN, L.L.C. 11/13/2024 1.13 M $40.76 B   100.00% 1.12%
VIVO CAPITAL, LLC 11/13/2024 1.11 M $40.05 M   -31.81% 1.11%
MORGAN STANLEY 11/14/2024 1.05 M $37.83 M   88.40% 1.04%
WOODLINE PARTNERS LP 11/14/2024 977,440 $35.11 M   -20.79% 0.97%
ARROWMARK COLORADO HOLDINGS LLC 11/14/2024 900,190 $32.33 M   -2.09% 0.89%
SOFINNOVA INVESTMENTS, INC. 11/13/2024 772,070 $27.73 B   -52.51% 0.77%
MAN GROUP PLC 11/14/2024 718,650 $25.81 M   100.00% 0.71%
PERCEPTIVE ADVISORS LLC 11/14/2024 718,144 $25.80 M   100.00% 0.71%
ORBIMED ADVISORS LLC 11/14/2024 708,400 $25.45 M   0.00% 0.70%
MPM ASSET MANAGEMENT LLC 11/13/2024 682,376 $24.51 M   -56.30% 0.68%
BAKER BROS. ADVISORS LP 11/14/2024 672,096 $24.14 M   0.00% 0.67%
GOLDMAN SACHS GROUP INC 11/14/2024 670,484 $24.08 M   -68.01% 0.66%
AVORO CAPITAL ADVISORS LLC 11/14/2024 650,000 $23.35 M   461.55% 0.64%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/12/2024 648,652 $23.30 M   7.92% 0.64%
UBS GROUP AG 11/14/2024 625,719 $22.48 M   156.52% 0.62%
ECOR1 CAPITAL, LLC 11/14/2024 555,644 $19.96 M   30.12% 0.55%
ROCK SPRINGS CAPITAL MANAGEMENT LP 11/14/2024 461,028 $16.56 M   0.00% 0.46%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 11/14/2024 435,653 $15.65 M   100.00% 0.43%
FARALLON CAPITAL MANAGEMENT LLC 11/14/2024 428,000 $15.37 M   7,033.33% 0.42%
VIDA VENTURES ADVISORS, LLC 10/08/2024 407,499 $14.64 M   0.00% 0.40%
CANDRIAM S.C.A. 11/13/2024 390,956 $14.04 M   -26.69% 0.39%
EVENTIDE ASSET MANAGEMENT, LLC 11/14/2024 332,277 $11.94 M   -31.49% 0.33%
WASATCH ADVISORS LP 11/14/2024 324,099 $11.64 M   -3.43% 0.32%
ENSIGN PEAK ADVISORS, INC 11/14/2024 312,752 $11.23 M   0.00% 0.31%
PICTET ASSET MANAGEMENT HOLDING SA 11/12/2024 304,705 $10.32 M   3.38% 0.30%
BANK OF AMERICA CORP /DE/ 11/14/2024 291,712 $10.48 M   65.02% 0.29%
NUVEEN ASSET MANAGEMENT, LLC 11/14/2024 276,414 $9.93 M   -56.38% 0.27%
OCTAGON CAPITAL ADVISORS LP 11/14/2024 262,726 $9.44 M   -77.75% 0.26%
VOYA INVESTMENT MANAGEMENT LLC 11/14/2024 248,320 $8.92 M   -2.33% 0.25%

Dyne Therapeutics, Inc.institutional Ownership - FAQ's

Who are the largest shareholders of DYN shares?

During the previous two years, 238 institutional investors and hedge funds held shares of Dyne Therapeutics, Inc.. The most heavily invested institutionals were:

FMR LLC: 9.03 M

Atlas Venture Life Science Advisors, LLC: 8.02 M

BlackRock Funding, Inc. /DE: 7.79 M

VANGUARD GROUP INC: 6.86 M

RTW INVESTMENTS, LP: 6.82 M

JANUS HENDERSON GROUP PLC: 6.81 M

What percentage of Dyne Therapeutics, Inc. stock is owned by institutional investors?

111.02% of Dyne Therapeutics, Inc. stock is owned by institutional investors.

How much institutional buying is happening at DYN ?

Institutional investors have bought a total of 117.59 M shares in the last 24 months. This purchase volume represents approximately $2.88 B in transactions.